B
B

BayerAG

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

CureVac 19 vaccine records only 48% efficacy in final trial readout

By Ludwig Burger June 30 (Reuters) - CureVac 5CV.DE said its COVID-19 vaccine was 48% effective in the final analysis of its pivotal mass trial, only marginally better than the 47% reported after an initial read-out two weeks ago. The German biotech firm said that efficacy, measured by preventing symptomatic disease, was slightly better at 53% when
B
G
N
P

CureVac may let contractors make rival vaccines if own shot fails -CEO

By Tilman Blasshofer and Ludwig Burger FRANKFURT, June 17 (Reuters) - German biotech firm CureVac 5CV.DE could allow its network of manufacturing partners to be repurposed to make vaccines developed by other companies should its own experimental shot fail, its chief executive told Reuters on Thursday. The German company saw billions of euros wiped
B
G
N
P
W

Swiss reject law to help country meet Paris carbon emissions goal

* Swiss voted on five issues in national referendums * New CO2 Law to help cut carbon emissions narrowly rejected * Voters against proposals to ban pesticides or reduce use * New terrorism laws which could affect 12-year-olds approved By John Revill ZURICH, June 13 (Reuters) - Swiss voters rejected a trio of environmental proposals on Sunday, inclu
B

Swiss voters look set to reject law to help cut carbon emissions

(Repeating to say pix are available, no changes to text) ZURICH, June 13 (Reuters) - Swiss voters look set to reject a new law which would help the country meet its goals under the Paris Agreement on Climate Change, according to early indications by national broadcaster SRF on Sunday. Projections showed 51% of voters had voted against the new CO2 l
B
B

Swiss voters look set to reject law to help cut carbon emissions

ZURICH, June 13 (Reuters) - Swiss voters look set to reject a new law which would help the country meet its goals under the Paris Agreement on Climate Change, according to early indications by national broadcaster SRF on Sunday. Projections showed 51% of voters had voted against the new CO2 law in a nationwide referendum conducted under the country
B
B

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.